# COVID-19 Serologic Strategies for Skilled Nursing Facilities

> **NCT05270980** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 87 (actual)

## Conditions studied

- COVID-19

## Interventions

- **OTHER:** Cohorting

## Key facts

- **NCT ID:** NCT05270980
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-11
- **Primary completion:** 2022-02-04
- **Final completion:** 2022-02-04
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2023-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05270980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05270980, "COVID-19 Serologic Strategies for Skilled Nursing Facilities". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05270980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*